Technology capable of disrupting an industry is often hard to find as an investor. Yet the reward of significant investment returns often lie in the identification of such opportunities prior to them becoming common knowledge. It is for this reason that I want to highlight a small company that has brought together a proprietary process that significantly evolves the field of research & development [R&D].
With a small market capitalization of $332 million, it may be easy to dismiss Intermolecular, Inc. (IMI). Yet to do so, would neglect the advancement of a new business model capable of introducing rapid accelerations to an inefficient and laborious process of R&D. The company maintains a proprietary process that streamlines the...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|